Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 126K 116K 107K 203K 13.72M 207K 1.39M 544K 6.74M 538K 527K 23.27M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.13M 18.64M 17.15M 32.44M 2.2B 33.08M 222M 87.14M 1.08B 86.17M 84.29M 3.73B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.28% | +2.11% | +21.54% | +0.35% | 196B | ||
| +0.08% | -5.94% | -20.49% | +17.34% | 144B | ||
| +0.56% | +3.38% | -2.29% | -16.18% | 142B | ||
| -0.27% | +0.11% | -56.73% | -15.42% | 66.37B | ||
| -0.46% | -3.56% | +17.60% | -1.40% | 52.85B | ||
| +2.80% | +1.95% | -22.83% | -30.55% | 45.22B | ||
| -0.19% | +2.63% | +8.73% | +12.31% | 37.86B | ||
| -0.85% | -1.50% | +5.76% | +38.61% | 36.64B | ||
| +0.94% | +0.72% | -13.07% | -19.77% | 29.71B | ||
| Average | +0.32% | -0.09% | -6.87% | -1.63% | 83.43B | |
| Weighted average by Cap. | +0.29% | -0.32% | -3.68% | -1.21% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.52M 1.4M 1.29M 2.44M 166M 2.49M 16.74M 6.57M 81.28M 6.49M 6.35M 281M | 1.98M 1.73M 1.61M 1.48M 2.8M 189M 2.85M 19.15M 7.51M 92.96M 7.43M 7.26M 321M |
| Net income | -16.08M -14.1M -13.06M -12.02M -22.73M -1.54B -23.17M -156M -61.05M -756M -60.37M -59.05M -2.61B | -29.31M -25.71M -23.81M -21.91M -41.44M -2.81B -42.25M -284M -111M -1.38B -110M -108M -4.76B |
| Net Debt | 20.53M 18M 16.67M 15.34M 29.02M 1.96B 29.58M 199M 77.94M 965M 77.08M 75.39M 3.33B | 22.8M 20M 18.53M 17.05M 32.24M 2.18B 32.87M 221M 86.6M 1.07B 85.63M 83.76M 3.7B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















